≥99% HPLCBatch testedIdentity by MS, purity by HPLC
Lot numberedCertificate filed per lot
Cold stored2 to 8 °C until dispatch
Ovagen
20mg lyophilised powder
A three-residue bioregulator-type peptide studied for gene-expression effects in liver and gut-lining cell cultures.
£39.90per vial, VAT included
In stock, dispatched same day before 16:00
- Free shipping on UK orders over £20.00
- Same day dispatch on orders placed before 16:00
- Batch certificate in the COA Database
Sold for research purposes only. For in-vitro laboratory research. Not a medicine and not for human or animal consumption. Supplied to qualified individuals aged 18 and over; you confirm this at checkout.
Research overview
Ovagen is a three-residue bioregulator-type peptide, Glu-Asp-Leu (EDL). It is studied for gene-expression effects in liver and gut-lining cell cultures, within the family of very short peptides described largely by the Khavinson group. Supplied at 20mg as a lyophilised powder for in-vitro laboratory research only.
Ovagen is described as the tripeptide linked to liver and gastrointestinal tissue in the bioregulator literature. Following the family model, it is proposed to enter cells and interact with DNA or chromatin proteins, modifying expression of genes characteristic of those tissues. In hepatocyte and intestinal epithelial cultures, studies cite changes in proliferation markers and in genes tied to cell senescence and metabolism. The data are limited to a few research groups, and independent confirmation is still needed.
Laboratory work uses hepatocyte cell lines, primary liver cultures and intestinal epithelial models such as Caco-2, with proliferation and viability assays, qPCR of tissue-specific genes, senescence staining and immunostaining of epithelial markers. Stability of the tripeptide in media is followed by HPLC. It is supplied as a lyophilised powder in a 20mg vial.
Research areas
- Hepatocyte gene expression
- Intestinal epithelial cell models
- Proliferation and viability assays
- Senescence staining in cultured cells
- Tripeptide stability in media
Specifications
- Molecular formula
- C15H25N3O8
- Molecular weight
- 375.38 g/mol
- Sequence
- Glu-Asp-Leu (EDL)
- Form
- lyophilised powder
- Purity
- ≥99% (HPLC)
- Also known as
- Ovagen; EDL; Glu-Asp-Leu
- Supplied as
- 20mg per vial, lyophilised powder
Storage and handling
Store the lyophilised powder in a freezer, protected from moisture and light, and let the vial reach room temperature before opening. Reconstitute with an appropriate laboratory diluent and keep reconstituted material cold.
Certificates of analysis
Each lot of Ovagen is released with a certificate recording identity and purity. Enter the lot number printed on your vial on the lab testing page to view it.
Questions
What is Ovagen made of?
It is the tripeptide Glu-Asp-Leu (EDL), a member of the short peptide bioregulator family. It is a single defined three-residue chain, not a tissue extract.
How is Ovagen supplied and stored?
It is supplied as a lyophilised powder in a 20mg vial. Keep it cold, dry and away from light, and reconstitute with a suitable laboratory diluent only when the material is needed.
Is Ovagen a medicine?
No. It is supplied strictly for in-vitro laboratory research. It is not a medicine, food or supplement, and it is not for human or animal use. Buyers must be aged 18 or over.
